Protective effect of caffeic acid phenethyl ester on oxidative stress in diabetic rat sciatic nerve

International Journal of Pharmacology

Volumn 8, Issue 6, 2012, Pages 577-581

  Yucel, Yavuz ^a   Celepkolu, Tahsin ^a   Kibrisli, Erkan ^a   Kilinc, Faruk ^a   Beyaz, Coskun ^a   Aluclu, Mehmet Ufuk ^a   Basarili, Mustafa Kemal ^a   Ekinci, Aysun ^b  

^a DICLE UNIVERSITY   (Turkey)

^b Obstetrics and Pediatrics Hospital ^*  (Turkey)

Author keywords

Curcumin; Diabetic rat; Oxidative stress; Sciatic nerve

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CAFFEIC ACID PHENETHYL ESTER; MALONALDEHYDE; NITRIC OXIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; FEMALE; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; SCIATIC NERVE;

EID: 84866135243     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2012.577.581     Document Type: Article

References (28)

1. Abbott, C.A., R.A. Malik, E.R. van Ross, J. Kulkarni and A.J. Boulton, 2011. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care, 34: 2220-2224.
2. Asilturk, Z., Y. Nazligul, M. Yildiz, M. Kucukazman and O. Bulur et al., 2011. Serum oxidative stress status in CagA positive Helicobacter pylori infection. J. Clin. Exp. Invest., 2: 202-206.
3. Celik, S. and S. Erdogan, 2008. Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats. Mol. Cell Biochem., 312: 39-46.
4. Celik, S., S. Erdogan and M. Tuzcu, 2009. Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats. Pharmacol. Res., 60: 270-276.
5. Cortas, N.K. and N.W. Wakid, 1990. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem., 36: 1440-1443.
6. Eckerson, H.W., C.M. Wyte and B.N. La Du, 1983. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet., 35: 1126-1138.
7. Erel, O., 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem., 37: 277-285.
8. Erel, O., 2005. A new automated colorimetric method for measuring total oxidant status. Clin. Biochem., 38: 1103-1111.
9. Figueroa-Romero, C., M. Sadidi and E.L. Feldman, 2008. Mechanisms of disease: The oxidative stress theory of diabetic neuropathy. Rev. Endocr. Metab. Disord., 9: 301-314.
10. Gurbuz, D.G., T. Ulas, F. Paksoy, O.K. Akgun and I. Tursun et al., 2011. The effect of intravenous iron therapy on total antioxidant capacity in patients with iron deficiency anemia. J. Clin. Exp. Invest., 2: 287-291.
11. Hoeldtke, R.D., K.D. Bryner and K. Vandyke, 2011. Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin. Auton. Res., 21: 19-28.
12. Ilhan, A., M. Iraz, A. Gurel, F. Armutcu and O. Akyol, 2004. Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice. Neurochem. Res., 29: 2287-2292.
13. Inoue, M., T. Suehiro, T. Nakamura, Y. Ikeda, Y. Kumon and K. Hashimoto, 2000. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes. Metabolism, 49: 1400-1405.
14. Kamboj, S.S., R.K. Vasishta and R. Sandhir, 2010. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J. Neurochem., 112: 77-91.
15. Kuhad, A. and K. Chopra, 2009. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology, 57: 456-462.
16. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275.
17. Lupachyk, S., H. Shevalye, Y. Maksimchyk, V.R. Drel and I.G. Obrosova, 2011. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: Correlation with peripheral nerve function. Free Radic. Biol. Med., 50: 1400-1409.
18. Negi, G., A. Kumar and S.S. Sharma, 2011. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: Effects on NF-?B and Nrf2 cascades. J. Pineal Res., 50: 124-131.
19. Negi, G., A. Kumar, R.K. Kaundal, A. Gulati and S.S. Sharma, 2010. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology, 58: 585-592.
20. Ohkawa, H., N. Ohishi and K. Yagi, 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95: 351-358.
21. Okutan, H., N. Ozcelik, H.R. Yilmaz and E. Uz, 2005. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin. Biochem., 38: 191-196.
22. Ozkul, A., M. Ayhan, C. Yenisey, A. Akyol, E. Guney and F.A. Ergin, 2010. The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol. Lett., 31: 261-264.
23. Park, S.H. and T.S. Min, 2006. Caffeic acid phenethyl ester ameliorates changes in IGFs secretion and gene expression in streptozotocin-induced diabetic rats. Life Sci., 78: 1741-1747.
24. Russell, J.W., A. Berent-Spillson, A.M. Vincent, C.L. Freimann, K.A. Sullivan, E.L. Feldman, 2008. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol. Dis., 30: 420-429.
25. Stefanovic, A., J. Kotur-Stevuljevic, S. Spasic, J. Vekic, A. Zeljkovic, V. Spasojevic-Kalimanovska and Z. Jelic-Ivanovic, 2010. HDL 2 Particles are associated with hyperglycaemia, lower PON1 activity and oxidative stress in type 2 diabetes mellitus patients. Clin. Biochem., 43: 1230-1235.
26. Uzar, E., H. Alp, M.U. Cevik, U. Firat, O. Evliyaoglu, A. Tufek and Y. Altun, 2012. Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol. Sci., 33: 567-574.
27. Uzar, E., Y. Tamam, O. Evliyaoglu, A. Tuzcu and C. Beyaz et al., 2012. Serum prolidase activity and oxidative status in patients with diabetic neuropathy. Neurol. Sci., 33: 875-880.
28. Yilmaz, H.R., E. Uz, N. Yucel, I. Altuntas and N. Ozcelik, 2004. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J. Biochem. Mol. Toxicol., 18: 234-238.